Our work delineate the underlying molecular mechanisms of BLCAP-mediated inhibition of STAT3 in cervical cancer, and we hypothesis that BLCAP may act as a new potential therapeutic target for various types of STAT3-activated carcinomas. The gene discussed is STAT3; the disease is cervical carcinoma.